Longitudinal non-interventional observational study on Adherence, safety and tolerability of AVANZ in adults and GRAZAX and SLIToneULTRA in adults and children (5 - 17 years) in patients with allergic Rhinoconjunctivitis in GErmany - LARGE
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Allergy immunotherapies; Allergy immunotherapies; Grass pollen allergy immunotherapy
- Indications Allergic rhinitis; Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- Acronyms LARGE
- Sponsors ALK-Abello
- 20 Jan 2015 Status changed from recruiting to active, no longer recruiting.
- 13 Jan 2014 Status changed from not yet recruiting to recruiting, according to German Clinical Trials Register record.
- 31 Jul 2013 New trial record